Iterum Therapeutics plc (ITRMF) Receivables - Other (2017 - 2022)

Iterum Therapeutics' Receivables - Other history runs 6 years deep, the most recent figure standing at $55000.0 for Q4 2022.

• In Q4 2022, Receivables - Other fell 81.03% year-over-year to $55000.0; the TTM figure through Dec 2022 stood at $55000.0 (down 81.03% YoY), while the FY2022 annual figure was $55000.0, down 81.03% from the prior year.
• Receivables - Other for Q4 2022 stood at $55000.0, down from $81000.0 in the prior quarter.
• The five-year high for Receivables - Other was $290000.0 in Q4 2021, with the low at $7000.0 in Q4 2019.
• The 5-year median for Receivables - Other is $111500.0 (2022), against an average of $119125.0.
• The sharpest annual moves came in 2019 and 2021: Receivables - Other slumped 95.57% in 2019, then soared 553.85% in 2021.
• Iterum Therapeutics' Receivables - Other stood at $158000.0 in 2018, then plunged by 95.57% to $7000.0 in 2019, then jumped by 85.71% to $13000.0 in 2020, then jumped by 2130.77% to $290000.0 in 2021, then sank by 81.03% to $55000.0 in 2022.
• Business Quant data shows ITRMF's Receivables - Other at $55000.0 in Q4 2022, $81000.0 in Q3 2022, and $123000.0 in Q2 2022.